- Home
- IPSC vs IINN Comparison
IPSC vs IINN Comparison
Compare IPSC & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- IINN
- Stock Information
- Founded
- IPSC 2019
- IINN 2018
- Country
- IPSC United States
- IINN Israel
- Employees
- IPSC N/A
- IINN N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- IINN Medical/Dental Instruments
- Sector
- IPSC Health Care
- IINN Health Care
- Exchange
- IPSC Nasdaq
- IINN Nasdaq
- Market Cap
- IPSC 43.2M
- IINN 40.4M
- IPO Year
- IPSC 2021
- IINN 2021
- Fundamental
- Price
- IPSC $0.56
- IINN $1.17
- Analyst Decision
- IPSC Strong Buy
- IINN Strong Buy
- Analyst Count
- IPSC 5
- IINN 1
- Target Price
- IPSC $3.33
- IINN $2.00
- AVG Volume (30 Days)
- IPSC 486.6K
- IINN 367.7K
- Earning Date
- IPSC 11-04-2025
- IINN 10-01-2025
- Dividend Yield
- IPSC N/A
- IINN N/A
- EPS Growth
- IPSC N/A
- IINN N/A
- EPS
- IPSC N/A
- IINN N/A
- Revenue
- IPSC $114,128,000.00
- IINN $289,000.00
- Revenue This Year
- IPSC $1,589.94
- IINN N/A
- Revenue Next Year
- IPSC N/A
- IINN $2,050.00
- P/E Ratio
- IPSC N/A
- IINN N/A
- Revenue Growth
- IPSC 5491.77
- IINN N/A
- 52 Week Low
- IPSC $0.34
- IINN $0.40
- 52 Week High
- IPSC $1.83
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- IPSC 60.86
- IINN 42.39
- Support Level
- IPSC $0.48
- IINN $1.16
- Resistance Level
- IPSC $0.51
- IINN $1.23
- Average True Range (ATR)
- IPSC 0.03
- IINN 0.06
- MACD
- IPSC 0.01
- IINN -0.01
- Stochastic Oscillator
- IPSC 67.79
- IINN 0.00
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.